SILO PHARMA INC (SILO)

US82711P2011 - Common Stock

0.9586  +0.08 (+8.51%)

Premarket: 0.9298 -0.03 (-3%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
70K70K72.1K
3.00%		73.44K
1.86%		73.44K73.44K73.44K73.44K73.44K175.84M
239,333.55%		376.42M
114.07%
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-2.75M
-25.00%		-3.63M
-32.00%		-3.856M
-6.21%		-4.559M
-18.25%		-9.574M
-109.98%		-17.153M
-79.17%		-26.938M
-57.04%		-39.054M
-44.98%		-48.396M
-23.92%		72.313M
249.42%		248.46M
243.59%
Operating Margin
-3,928.57%-5,185.71%-5,347.56%-6,208.33%-13,036.11%-23,356.94%-36,680.56%-53,177.78%-65,898.61%41.12%66.01%
EPS
YoY % growth
N/AN/AN/A-0.57
45.10%		-0.71
-25.00%		-0.73
-2.86%		-1.14
-55.56%		-1.23
-8.04%		-1.52
-23.14%		1.32
186.58%		4.42
235.66%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.36 -0.20-0.16-76.47%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 18.03K
-9.85%		%
Q2 2024
Q2Q % growth		 18.03K
-9.85%		%
Q1 2024
Q2Q % growth		 18.03K
-9.85%		%
Q4 2023
Q2Q % growth		 18.03K
-9.85%		18.36K-330-1.80%
Q3 2023
Q2Q % growth		 20K %
Q2 2023
Q2Q % growth		 20K %
Q1 2023
Q2Q % growth		 20K %
Q4 2022
Q2Q % growth		 20K %
Q3 2022
Q2Q % growth		 20K %
Q2 2022
Q2Q % growth		 20K %
Q1 2022
Q2Q % growth		 20K %
Q4 2020
Q2Q % growth
-100.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%